FATE THERAPEUTICS INC
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-30.2M | $-31.2M | $-32.4M | $-32.3M | $-34.1M | $-37.6M | $-52.2M | $-47.7M |
| Depreciation & Amortization | $2.8M | $2.9M | $3.1M | $3.2M | $3.3M | $3.3M | $4.8M | $4.6M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-23.4M | $-30.8M | $-23.3M | $-24.4M | $-24.6M | $-33.8M | $-27.8M | $-29.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $80.0K | $239.0K | $1.2M | $2.2M | $1.4M | $1.2M | $98.0K | $495.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $14.6M | $23.6M | $27.6M | $21.3M | $19.6M | $42.7M | $22.8M | $25.5M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $1.7M | $2.5M | $1.3M | $0 | $3.1M | $0 |
| Net Change in Cash | $-7.1M | $-7.2M | $6.0M | $-627.0K | $-3.7M | $8.9M | $-1.9M | $-4.0M |
| Free Cash Flow | $-23.5M | $-31.1M | $-24.5M | $-26.6M | $-25.9M | $-35.0M | $-27.9M | $-29.9M |